HOME >> MEDICINE >> NEWS
Prebiotics can cut development of skin allergy in babies at high risk

Prebiotics can cut the chances of developing atopic dermatitis in babies at high risk of the disorder, suggests a study published ahead of print in the Archives of Disease in Childhood .

Human breast milk contains natural prebiotics (oligosaccharides), which promote the growth of bacteria, such as lactobacilli and bifidobacteria that boost the development of a healthy immune system.This can help prevent allergies in a very young child.

Researchers developed an infant formula based on the prebiotic content of human breast milk and tested it out on a group of babies one of other of whose parents had atopic eczema, or allergic rhinitis, or asthma.

All the mothers were advised to breastfeed their babies, all of whom were born after a normal length pregancy. But for those unable to start or continue, their babies were divided into two groups, with 102 given a prebiotic formula feed and 104 given a normal formula.

The babies were seen on a monthly basis up to the age of 6 months, and their parents kept a symptom diary.

Over the six months, only 10 babies fed the prebiotic formula developed atopic dermatitis, compared with 24 fed the normal formula. An assessment of stool samples from 98 of the babies showed a significant increase in bifidobacteria in those fed the prebiotic feed.

This strongly suggests that formula feed supplemented with prebiotics can modify the bowel bacteria and so reduce the chance of developing atopic dermatitis among children at high risk of the disorder


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
440-207-383-6529
BMJ Specialty Journals
26-Jul-2006


Page: 1

Related medicine news :

1. Baby DVDs, videos may hinder, not help, infants language development
2. Millennium development goals: Are we on track?
3. New drug development facility helps move medicines to market
4. Mid Sweden University leads development of digital color x-rays
5. NIH study tracks brain development in some 500 children across US
6. A first glimpse at healthy brain and behavioral development
7. Role of TRPM8 in the development of prostate cancer
8. SLEEP 2007 to present more than 1,100 new findings and developments on sleep disorders
9. Hebrew University research shows developmental problems for siblings of autistic children
10. New forecasting tool could reduce drug development costs
11. Pittsburgh ear study finds that fluid in the ear does not impair development in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... 28, 2017 , ... Datta Endoscopic Back Surgery and Pain ... endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with additional ... eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back surgery ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec ... Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to their ... expert that specializes in long-term care, Brooke Grove now has the capability to ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins ... athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 24, 2017 Solentim, the developer of ... addition of a major new product line called ... The VIPS has been developed for automatically seeding ... as part of the process to generate clonally-derived ... and more reliable solution when compared to traditional ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology:
Cached News: